Non-Invasive Imaging of Atherosclerosis

Completed

Conditions studied: Atherosclerosis

In brief

The purpose of this study is to develop and validate novel magnetic resonance imaging (MRI), dynamic contrast enhanced (DCE)-MRI and positron emission tomography (PET)/MR techniques for the detection and risk stratification of patients with atherosclerosis.

Key facts

Study ID

NCT01418313

Run by

Icahn School of Medicine at Mount Sinai

People needed

886

Starts

2011-09-01

Expected to finish

2020-03-09

Last updated by the study team

2020-08-03

Who can join

Age: 20 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Volunteers with carotid artery disease who are MRI and CT compatible.
• All subjects will have either a
• clinical diagnosis of atherosclerosis,
• and/or risk factors
• and/or family history of disease

You may not qualify if…

• Glomerular filtration rate <30mg/ml (for MRI with contrast)
• Subjects who have any ferromagnetic implants (e.g. aneurysm clip, ICD, pacemaker, etc.) or a condition that may be contraindicated for the MRI procedure (e.g. claustrophobia )
• Pregnant patients will be excluded from the present study.

Where it is running

• Icahn School of Medicine at Mount Sinai — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.